Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Steef Konings"'
Autor:
Mark van der Gaag, Mickaël Hiligsmann, Wim Veling, Frederick W. Thielen, Steef Konings, Talitha L Feenstra, Joran Lokkerbol, Filip Smit, Silvia M. A. A. Evers, Helga K. Ising, Ben F. M. Wijnen, Lieuwe de Haan
Publikováno v:
Expert review of pharmacoeconomics & outcomes research. Taylor & Francis Ltd
Expert Review of Pharmacoeconomics & Outcomes Research, 20(3), 269-279. Routledge/Taylor & Francis Group
Wijnen, B F M, Thielen, F W, Konings, S, Feenstra, T, Van Der Gaag, M, Veling, W, De Haan, L, Ising, H, Hiligsmann, M, Evers, S M A A, Smit, F & Lokkerbol, J 2020, ' Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 20, no. 3, pp. 269-279 . https://doi.org/10.1080/14737167.2019.1632194
Expert Review of Pharmacoeconomics and Outcomes Research, 20(3), 269-279. Expert Reviews Ltd.
Wijnen, B F M, Thielen, F W, Konings, S, Feenstra, T, van der Gaag, M, Veling, W, de Haan, L, Ising, H, Hiligsmann, M, Evers, S M A A, Smit, F & Lokkerbol, J 2020, ' Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis ', Expert review of pharmacoeconomics & outcomes research, vol. 20, no. 3, pp. 269-279 . https://doi.org/10.1080/14737167.2019.1632194
Expert review of pharmacoeconomics & outcomes research. Taylor & Francis Group
Expert review of pharmacoeconomics & outcomes research, 20(3), 269-279. Taylor and Francis Ltd.
Expert Review of Pharmacoeconomics & Outcomes Research, 20(3), 269-279. Routledge/Taylor & Francis Group
Wijnen, B F M, Thielen, F W, Konings, S, Feenstra, T, Van Der Gaag, M, Veling, W, De Haan, L, Ising, H, Hiligsmann, M, Evers, S M A A, Smit, F & Lokkerbol, J 2020, ' Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 20, no. 3, pp. 269-279 . https://doi.org/10.1080/14737167.2019.1632194
Expert Review of Pharmacoeconomics and Outcomes Research, 20(3), 269-279. Expert Reviews Ltd.
Wijnen, B F M, Thielen, F W, Konings, S, Feenstra, T, van der Gaag, M, Veling, W, de Haan, L, Ising, H, Hiligsmann, M, Evers, S M A A, Smit, F & Lokkerbol, J 2020, ' Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis ', Expert review of pharmacoeconomics & outcomes research, vol. 20, no. 3, pp. 269-279 . https://doi.org/10.1080/14737167.2019.1632194
Expert review of pharmacoeconomics & outcomes research. Taylor & Francis Group
Expert review of pharmacoeconomics & outcomes research, 20(3), 269-279. Taylor and Francis Ltd.
BACKGROUND: This study aims to report on the design of a model to determine the cost-effectiveness of prevention and treatment of early psychosis (PsyMod) and to estimate ten-year cost-effectiveness and budget impact of interventions targeting indivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02debc7401b9508310ef1c0c869f7219
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068155768&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068155768&origin=inward
